Under pressure from Public Citizen and FDA, Dermatologic and Ophthalmic Drugs Advisory Committee chair Lynn Drake withdrew her acceptance of an invitation to provide a presentation to industry on winning a favorable panel endorsement.
On Oct. 24, Public Citizen Health Research Group senior advisor Sidney Wolfe complained to FDA about a conference brochure touting her presentation under the title, “FDA Advisory Committee Prep: Real World Best Practices to Achieve Favorable Recommendations.”
This, Wolfe told FDA, “seriously undermines and demeans the important FDA advisory committee process, particularly when the chair seeks to help drug companies get drugs approved.”
Reached by Reuters, Drake said she had not fully understood the nature of the meeting. “It was my understanding that this was an educational program,” she said, adding that she was neither offered nor asked for payment beyond her expenses.
FDA was contacted prior to Drake accepting the invitation to make the presentation, she said, and did not object. “It appears that Dr. Drake was not given a full understanding by the conference organizers of how she and her role at this conference would be characterized,” the agency said in a statement.
Wolfe said the episode demonstrated the need for better FDA ethics training for outside advisors.